Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancer

21 Jan 2025

Abstract excerpt

Emerging evidence has shown that the N 6 -methyladenosine (m 6 A) modification of RNA plays key roles in tumorigenesis and the progression of various cancers. However, the potential roles of the m 6 A modification of long noncoding RNAs (lncRNAs) in pancreatic cancer (PaCa) are still unknown. To analyze the prognostic value of m 6 A-related lncRNAs in PaCa, an m6A-related lncRNA signature was constructed as a...

Topics

Join the communities discussing this publication.

Cancer-related molecular mechanisms research
Cholangiocarcinoma and Gallbladder Cancer Studies
RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39833465
DOI: 10.1007/s00018-024-05573-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancerPMID 39833465Read ↗

N6-methyladenosine-related long noncoding RNA is a potential biomarker for predicting pancreatic cancer prognosisSemantic proximity Read ↗

Prognostic Value of Drug Targets Predicted using Deep Bioinformatic Analysis of M6A-associated lncRNA-based Pancreatic Cancer Model Characteristics and its Tumour MicroenvironmentSemantic proximity Read ↗

m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic CancerSemantic proximity Read ↗

Role of N6-methyladenosine Regulated lncRNAs in Prognosis, Tumor Microenvironment and Immune Checkpoints of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinomaSemantic proximity Read ↗

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerSemantic proximity Read ↗

N6-Methylandenosine-Related lncRNAs Play an Important Role in the Prognosis and Immune Microenvironment of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Potential value of m6A-related lncRNAs in diagnosis and therapy of pancreatic cancerSemantic proximity Read ↗

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinomaSemantic proximity Read ↗

m1A Regulator ALKBH1 and TRMT10B as Potential Prognostic Biomarkers and Related to Tumor Immune Microenvironment in Pancreatic AdenocarcinomaSemantic proximity Read ↗

m1A Regulator ALKBH1 and TRMT10B as Potential Prognostic Biomarkers and Related to Tumor Immune Microenvironment in Pancreatic AdenocarcinomaSemantic proximity Read ↗

Aerial View of the Association between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.